UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant ☒ Filed by a party other than the Registrant ☐
Check the appropriate box:
☐ | Preliminary Proxy Statement |
☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☐ | Definitive Proxy Statement |
☒ | Definitive Additional Materials |
☐ | Soliciting Material Pursuant to §240.14a-12 |
MEDICAL PROPERTIES TRUST, INC.
(Name of Registrant as Specified in its Charter)
Not applicable.
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
☒ | No fee required. | |||
☐ | Fee paid previously with preliminary materials. | |||
☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
Your Vote Counts! MEDICAL PROPERTIES TRUST, INC. 2024 Annual Meeting Vote by May 29, 2024 11:59 PM ET You invested in MEDICAL PROPERTIES TRUST, INC. and its time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy material for the shareholder meeting to be held on May 30, 2024. Get informed before you vote View the Notice & Proxy Statement, and the Annual Report to stockholders online OR you can receive a free paper or email copy of the material(s) by requesting prior to May 20, 2024. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. For complete information and to vote, visit www.ProxyVote.com Control # XXXX XXXX XXXX XXXX Smartphone users Vote in Person at the Meeting* Point your camera here and May 30, 2024 vote without entering a 10:30 AM CST control number UAB Collat School of Business 710 13th Street South Birmingham, Alabama 35233 *If you choose to vote these shares in person at the meeting, you must request a legal proxy. To do so, please follow the instructions at www.ProxyVote.com or request apaper copy of the materials, which will contain the appropriate instructions. Please check the meeting materials for any special requirements for meeting attendance.
Vote at www.ProxyVote.com Control # XXXX XXXX XXXX XXXX THIS IS NOT A VOTABLE BALLOT MEDICAL PROPERTIES TRUST, INC. This is an overview of the proposals being presented at the 2024 Annual Meeting Vote by May 29, 2024 upcoming shareholder meeting. Please follow the instructions on 11:59 PM ET the reverse side to vote these important matters. Voting Items Board Recommends 1A Election of Director: Edward K. Aldag, Jr. For 1B Election of Director: G. Steven Dawson For 1C Election of Director: R. Steven Hamner For 1D Election of Director: Caterina A. Mozingo For 1E Election of Director: Emily W. Murphy For 1F Election of Director: Elizabeth N. Pitman For 1G Election of Director: D. Paul Sparks, Jr. For 1H Election of Director: Michael G. Stewart For 1I Election of Director: C. Reynolds Thompson, III For 2 To ratify the appointment of PricewaterhouseCoopers LLP as the Companys independent registered public For accounting firm for the fiscal year ending December 31, 2024. 3 To approve, on a non-binding, advisory basis, the compensation of the Companys named executive officers. For NOTE: Such other business as may properly come before the meeting or any adjournment thereof. Under New York Stock Exchange rules, brokers may vote routine matters at their discretion if your voting instructions are not communicated to us at least 10 days before the meeting. We will nevertheless follow your instructions, even if the brokers discretionary vote has already been given, provided your instructions are received prior to the meeting date.